Clincosm LogoSign in Get a demo

bioequivalence

Showing 26 - 50 of 151
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bioequivalence Trial (Sulfadoxine/Pyrimethamine dispersible tablets, 250 mg sulfadoxine / 12.5 mg pyrimethamine & 500 mg

Not yet recruiting
  • Bioequivalence
  • Sulfadoxine/Pyrimethamine dispersible tablets, 250 mg sulfadoxine / 12.5 mg pyrimethamine & 500 mg sulfadoxine / 25 mg pyrimethamine
  • G-COSPE® tablets
  • (no location specified)
Aug 9, 2022

Bioequivalence Trial in Lausanne (Treatment A (investigational drug) followed by Treatment B (reference drug), Treatment B

Not yet recruiting
  • Bioequivalence
  • Treatment A (investigational drug) followed by Treatment B (reference drug)
  • Treatment B (reference drug) followed by Treatment A (investigational drug)
  • Lausanne, Switzerland
    University Hospital CHUV, Service of Clinical Pharmacology
Jul 25, 2022

Bioequivalence, Healthy Subjects Trial in Amman (PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg

Completed
  • Bioequivalence
  • Healthy Subjects
  • PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg amlodipine tablets
  • TRIPLIXAM® 10 mg /2.5 mg/10 mg, 10 mg perindopril arginine / 2.5 mg indapamide / 10 mg amlodipine film-coated tablets
  • Amman, Jordan
    International Pharmaceutical Research Center
Jul 20, 2022

Bioequivalence, Healthy Subjects Trial in Amman (PERINDOPRES® DUO 8 mg perindopril tert-butylamine / 2.5 mg indapamide tablets,

Completed
  • Bioequivalence
  • Healthy Subjects
  • PERINDOPRES® DUO 8 mg perindopril tert-butylamine / 2.5 mg indapamide tablets
  • Noliterax® 10 mg/2.5 mg 10 mg perindopril arginine / 2.5 mg indapamide film-coated tablets
  • Amman, Jordan
    International Pharmaceutical Research Center
Jul 18, 2022

Bioequivalence Trial in Glendale, Brooklyn, Salt Lake City (Treatment A: Acalabrutinib tablet, Treatment B: Acalabrutinib

Completed
  • Bioequivalence
  • Treatment A: Acalabrutinib tablet
  • Treatment B: Acalabrutinib capsule
  • Glendale, California
  • +2 more
Jul 7, 2022

Bioequivalence Trial in Yaroslavl (Lisinopril tablet 20 mg, Zestril® tablet 20 mg)

Completed
  • Bioequivalence
  • Lisinopril tablet 20 mg
  • Zestril® tablet 20 mg
  • Yaroslavl, Yaroslavl Region, Russian Federation
    Private healthcare institution "Clinical Hospital "RZD-Medicine"
Jul 4, 2022

Bioequivalence Trial in Saint Petersburg (Aceclofenac film-coated tablet 100 mg, Airtal® film-coated tablet 100 mg)

Active, not recruiting
  • Bioequivalence
  • Aceclofenac film-coated tablet 100 mg
  • Airtal® film-coated tablet 100 mg
  • Saint Petersburg, Russian Federation
    X7 Clinical Research
Jun 29, 2022

Bioequivalence Trial in Moscow (Ramipril tablet 10 mg / Tritace® tablet 10 mg)

Recruiting
  • Bioequivalence
  • Ramipril tablet 10 mg / Tritace® tablet 10 mg
  • Moscow, Russian Federation
    Ligand Research LLC
Jun 24, 2022

Bioequivalence Trial in Auckland (APL-101, PLB-1001)

Recruiting
  • Bioequivalence
  • Auckland, New Zealand
    New Zealand Clinical Research
Jun 13, 2022

Asthma, Bioequivalence Trial in Larissa (Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent

Active, not recruiting
  • Asthma
  • Bioequivalence
  • Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals
  • FLOVENT DISKUS
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
May 25, 2022

Bioequivalence Trial in Baltimore (Metronidazole gel 1, Metronidazole gel 2, Metronidazole cream)

Completed
Has Results
  • Bioequivalence
  • Metronidazole gel 1
  • +2 more
  • Baltimore, Maryland
    General Clinical Research Center (GCRC) at the University of Mar
Mar 3, 2022

Bioequivalence Trial in Lenexa (Pharmaceutical-lipid aspirin (PL-ASA))

Completed
  • Bioequivalence
  • Pharmaceutical-lipid aspirin (PL-ASA)
  • Lenexa, Kansas
    PRA-EDS
Apr 20, 2022

Bioequivalence Trial in Chennai (Eszopiclone 3mg Test Drug T-1 Coated Tablets, Eszopiclone 3mg Test Drug T-2 Coated Tablets,

Completed
  • Bioequivalence
  • Eszopiclone 3mg Test Drug T-1 Coated Tablets
  • +2 more
  • Chennai, Tamil Nadu, India
    Azidus Laboratories Ltd.
Apr 22, 2022

Bioequivalence Trial in Chennai (Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet, Estradiol Valerate and Dienogest

Completed
  • Bioequivalence
  • Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet
  • Estradiol Valerate and Dienogest 2 mg/ 2 mg Reference Product tablet
  • Chennai, Tamil Nadu, India
    Azidus Laboratories Ltd.
Apr 11, 2022

Bioequivalence Trial in Karachi (Moksi® 400mg Tablet, Drug: Avelox® 400Mg Tablet)

Completed
  • Bioequivalence
  • Moksi® 400mg Tablet
  • Drug: Avelox® 400Mg Tablet
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and Clinical Research (CBSCR)
Mar 31, 2022

Irbesartan Tablets (0.15g/Tablet), Under Fasted Condition, Under Fed Condition Trial in Qingdao (Irbesartan Tablet)

Recruiting
  • Irbesartan Tablets (0.15g/Tablet)
  • +3 more
  • Irbesartan Tablet
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Mar 17, 2022

Bioequivalence Trial in Chennai (Levodopa 250mg and Carbidopa 25mg Test Drug tablet, Levodopa 250mg and Carbidopa 25mg Referent

Completed
  • Bioequivalence
  • Levodopa 250mg and Carbidopa 25mg Test Drug tablet
  • Levodopa 250mg and Carbidopa 25mg Referent Product tablet
  • Chennai, Tamil Nadu, India
    Azidus Laboratories Ltd.
Mar 7, 2022

Bioequivalence Trial in Karachi (Clopid® 75 mg Tablet, Plavix® 75mg Tablet)

Completed
  • Bioequivalence
  • Clopid® 75 mg Tablet
  • Plavix® 75mg Tablet
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and Clinical Research (CBSCR)
Feb 14, 2022

Bioequivalence Trial in Chennai (Diosmin/Hesperidin (90/10) 500 mg Test Drug, Diosmin/Hesperidin (90/10) 500 mg Reference

Completed
  • Bioequivalence
  • Diosmin/Hesperidin (90/10) 500 mg Test Drug
  • Diosmin/Hesperidin (90/10) 500 mg Reference Product
  • Chennai, Tamil Nadu, India
    Azidus Laboratories Ltd.
Feb 10, 2022

Bioequivalence Trial in Cairo (Test product (T) 40 mg Hard Gelatin Capsules, Reference product (R) 40 mg Hard Gelatin Capsules)

Completed
  • Bioequivalence
  • Test product (T) 40 mg Hard Gelatin Capsules
  • Reference product (R) 40 mg Hard Gelatin Capsules
  • Cairo, Egypt
    Future Research Center (FRC)
Feb 10, 2022

Bioequivalence Trial in Cairo (Test product (T) 25 mg Film Coated Tablets, Reference product (R) 25 mg Film Coated Tablets)

Completed
  • Bioequivalence
  • Test product (T) 25 mg Film Coated Tablets
  • Reference product (R) 25 mg Film Coated Tablets
  • Cairo, Egypt
    Future Research Center (FRC)
Feb 10, 2022

Bioequivalence Trial in Lesnoy (Aviga, capsules 50 mg / Sutent®, capsules 50 mg, Sutent®, capsules 50 mg / Aviga, capsules 50

Not yet recruiting
  • Bioequivalence
  • Aviga, capsules 50 mg / Sutent®, capsules 50 mg
  • Sutent®, capsules 50 mg / Aviga, capsules 50 mg
  • Lesnoy, Minsk Region, Belarus
    National Anti-Doping Laboratory
Jan 20, 2022

Bioequivalence Trial in Cairo (Rosuvastatin 10 mg)

Completed
  • Bioequivalence
  • Rosuvastatin 10 mg
  • Cairo, Egypt
    Future Research Center (FRC)
Jan 19, 2022

Docetaxel, Solid Tumours, Bioequivalence Trial in Andra, Gujrat, Mahara (BH009 (Docetaxel injection), Docetaxel injection)

Completed
  • Docetaxel
  • +2 more
  • BH009 (Docetaxel injection)
  • Docetaxel injection
  • Andra, India
  • +2 more
Dec 20, 2021

Bioequivalence, Safety Trial in Mount-Royal (Fingolimod 0.5 mg capsules- Test drug)

Completed
  • Bioequivalence
  • Safety
  • Fingolimod 0.5 mg capsules- Test drug
  • Mount-Royal, Quebec, Canada
    Algorithme Pharma Inc.
Dec 6, 2021